ULTRAGENYX PHARMACEUTICAL INC.

NOVATO, CA How do I update this listing?

Ultragenyx Pharmaceutical is based out of Novato. Ultragenyx Pharmaceutical Inc. provides biotechnology services. The company develops therapeutics and sialic acid for treating metabolic, body myopathy, glucuronidase, and rare genetic diseases. Ultragenyx Pharmaceutical conducts its business in the United States.Whalewisdom has at least 4 13D filings, and 189 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2012-12-31. The notice included securities offered of Equity

Create Alert

Contact Info

ultragenyx pharmaceutical inc.
60 LEVERONI COURT
NOVATO CA    94949

Business Phone: 415-483-8800
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS
Current 13D/G Holdings
Stock Sector Shares Held Market Value Rank Source Source Date
Arcturus Therapeutics Ltd (ARCT) HEALTH CARE 2,200,000 95,436,000.00 1 13D 2020-12-08
Solid Biosciences Inc (SLDB) HEALTH CARE 7,825,797 59,319,541.26 2 13D 2020-10-22

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2012-12-31 D BIOTECHNOLOGY Equity 75,000,005 75,000,005 0
2012-07-30 D BIOTECHNOLOGY Equity 30,100,000 15,100,000 15,000,000
2011-06-23 D BIOTECHNOLOGY Equity 48,664,443 18,664,443 30,000,000
2011-03-16 D PHARMACEUTICALS Equity 133 133 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
BEN AUSPITZ subscription required
    DIRECTOR
BILL ALISKI subscription required
    DIRECTOR
CORDELIA LEONARD subscription required
    EXECUTIVE OFFICER
EMIL KAKKIS subscription required
    EXECUTIVE OFFICER DIRECTOR
ERAN NADAV subscription required
    DIRECTOR
JENNY SORIANO subscription required
    DIRECTOR
JOHN DITTON subscription required
    EXECUTIVE OFFICER
JOHN KLOCK subscription required
    DIRECTOR
MARTEN STEEN subscription required
    DIRECTOR
SHALINI SHARP subscription required
    EXECUTIVE OFFICER
STEVEN JUNGLES subscription required
    EXECUTIVE OFFICER
THOMAS KASSBERG subscription required
    EXECUTIVE OFFICER
VIMAL SRIVASTAVA subscription required
    EXECUTIVE OFFICER
WILLIAM ALISKI subscription required
    DIRECTOR

Elevate your investments